Disc Medicine Quarterly Cash Flow Statement
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
62.06+1.29 (+2.12%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Disc Medicine free cash flow
In the quarter ended Jun 30, 2026, Disc Medicine generated -$44.2 million of operating cash flow and spent $0 on capital expenditures. That left free cash flow of -$44.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
Disc Medicine cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -59.53M | -63.50M | -60.53M | -62.32M | -55.25M | -34.09M | -29.46M | -26.60M | -26.35M | -26.95M | -23.58M | -14.12M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 90.00K | 89.00K | 89.00K | 87.00K | 85.00K | 20.00K | 9.00K | 11.00K | 110.00K | 26.00K | 25.00K | 25.00K |
| Stock-Based Compensation | 13.95M | 11.95M | 10.04M | 9.51M | 8.42M | 6.36M | 4.33M | 4.33M | 4.09M | 4.06M | 1.93M | 1.27M |
| Change in Working Capital | -2.64M | -1.80M | 368.00K | 1.29M | -1.00M | -8.51M | 6.47M | 60.00K | 1.83M | -10.80M | 6.69M | 5.04M |
| Operating Cash Flow | -44.20M | -62.24M | -43.30M | -47.80M | -47.92M | -41.38M | -27.57M | -17.36M | -15.39M | -33.60M | -17.80M | -7.48M |
| Capital Expenditures | 0 | 0 | -20.00K | -26.00K | -36.00K | -851.00K | -449.00K | 8.00K | 3.00K | -67.00K | -3.00K | -45.00K |
| Investing Cash Flow | 21.63M | 58.31M | -222.89M | 49.54M | 51.69M | -272.63M | -1.43M | -71.09M | -219.75M | -67.00K | -3.00K | -45.00K |
| Financing Cash Flow | 32.34M | 1.70M | 216.68M | 11.59M | 892.00K | 244.25M | 28.80M | 426.00K | 173.19M | 15.90M | 7.76M | 460.00K |
| Net Change in Cash | 9.76M | -2.23M | -49.52M | 13.33M | 4.66M | -69.76M | -202.00K | -88.03M | -61.95M | -17.77M | -10.04M | -7.06M |
| Free Cash Flow | -44.20M | -62.24M | -43.32M | -47.83M | -47.95M | -42.23M | -28.02M | -17.35M | -15.39M | -33.67M | -17.80M | -7.52M |
This table shows 12 quarterly periods of Disc Medicine's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRON's reporting calendar. What is a cash flow statement?